Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in Hippo-dependent cancer models [ATAC-seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 30 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 30 samples: 10 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE330305_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1463356 and SRA study SRP698473. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 30 samples.
How we read this: 10 replicated groups read from 30 sample titles; they account for 30 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9723405 ATAC-seq NCI-H226 xenograft tumor Vehicle rep1 ATAC-seq NCI-H226 xenog…
- GSM9723406 ATAC-seq NCI-H226 xenograft tumor Vehicle rep2 ATAC-seq NCI-H226 xenog…
- GSM9723407 ATAC-seq NCI-H226 xenograft tumor Vehicle rep3 ATAC-seq NCI-H226 xenog…
- GSM9723408 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.025 mg/kg rep1 ATAC-seq NCI-H226 xenog…
- GSM9723409 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.025 mg/kg rep2 ATAC-seq NCI-H226 xenog…
- GSM9723410 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.025 mg/kg rep3 ATAC-seq NCI-H226 xenog…
- GSM9723411 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.05 mg/kg rep1 ATAC-seq NCI-H226 xenog…
- GSM9723412 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.05 mg/kg rep2 ATAC-seq NCI-H226 xenog…
- GSM9723413 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.05 mg/kg rep3 ATAC-seq NCI-H226 xenog…
- GSM9723414 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.1 mg/kg rep1 ATAC-seq NCI-H226 xenog…
- GSM9723415 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.1 mg/kg rep2 ATAC-seq NCI-H226 xenog…
- GSM9723416 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.1 mg/kg rep3 ATAC-seq NCI-H226 xenog…
- GSM9723417 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.25 mg/kg rep1 ATAC-seq NCI-H226 xenog…
- GSM9723418 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.25 mg/kg rep2 ATAC-seq NCI-H226 xenog…
- GSM9723419 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.25 mg/kg rep3 ATAC-seq NCI-H226 xenog…
- GSM9723420 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.5 mg/kg rep1 ATAC-seq NCI-H226 xenog…
- GSM9723421 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.5 mg/kg rep2 ATAC-seq NCI-H226 xenog…
- GSM9723422 ATAC-seq NCI-H226 xenograft tumor GNE-8025 0.5 mg/kg rep3 ATAC-seq NCI-H226 xenog…
- GSM9723423 ATAC-seq NCI-H226 xenograft tumor GNE-8025 1.5 mg/kg rep1 ATAC-seq NCI-H226 xenog…
- GSM9723424 ATAC-seq NCI-H226 xenograft tumor GNE-8025 1.5 mg/kg rep2 ATAC-seq NCI-H226 xenog…
- GSM9723425 ATAC-seq NCI-H226 xenograft tumor GNE-8025 1.5 mg/kg rep3 ATAC-seq NCI-H226 xenog…
- GSM9723426 ATAC-seq NCI-H226 xenograft tumor GNE-8025 5 mg/kg rep1 ATAC-seq NCI-H226 xenog…
- GSM9723427 ATAC-seq NCI-H226 xenograft tumor GNE-8025 5 mg/kg rep2 ATAC-seq NCI-H226 xenog…
- GSM9723428 ATAC-seq NCI-H226 xenograft tumor GNE-8025 5 mg/kg rep3 ATAC-seq NCI-H226 xenog…
- GSM9723429 ATAC-seq NCI-H226 xenograft tumor GNE-8025 10 mg/kg rep1 ATAC-seq NCI-H226 xenog…
- GSM9723430 ATAC-seq NCI-H226 xenograft tumor GNE-8025 10 mg/kg rep2 ATAC-seq NCI-H226 xenog…
- GSM9723431 ATAC-seq NCI-H226 xenograft tumor GNE-8025 10 mg/kg rep3 ATAC-seq NCI-H226 xenog…
- GSM9723432 ATAC-seq NCI-H226 xenograft tumor GNE-8025 25 mg/kg rep1 ATAC-seq NCI-H226 xenog…
- GSM9723433 ATAC-seq NCI-H226 xenograft tumor GNE-8025 25 mg/kg rep2 ATAC-seq NCI-H226 xenog…
- GSM9723434 ATAC-seq NCI-H226 xenograft tumor GNE-8025 25 mg/kg rep3 ATAC-seq NCI-H226 xenog…
- GSE305254 Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in Hippo-dependent cancer models 299 samples shares yap, hippo-dependent, demonstrate, inhibitors, penetrance, covalent, pan-tead, activity
- GSE305227 Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in Hippo-dependent cancer models [Quant-seq] 149 samples shares yap, hippo-dependent, demonstrate, inhibitors, penetrance, covalent, pan-tead, activity
- GSE305224 Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in Hippo-dependent cancer models [RNA-seq] 120 samples shares yap, hippo-dependent, demonstrate, inhibitors, penetrance, covalent, pan-tead, activity
- GSE235968 A non-canonical repressor function of JUN restrains YAP activity and suppresses YAP-dependent liver cancer growth 178 samples shares yap, activity
- GSE235960 A non-canonical repressor function of JUN restrains YAP activity and suppresses YAP-dependent liver cancer growth [CUT&RUN] 64 samples shares yap, activity
- GSE235965 A non-canonical repressor function of JUN restrains YAP activity and suppresses YAP-dependent liver cancer growth [iYAP5SA_10A_JUN_oe_antibodies_for_JUN_YAP_TEAD] 54 samples shares yap, activity
- GSE227974 MY-COMP, an inhibitor of the transcriptional activity of YAP-B-MYB, identifies NEK2 as a novel mediator of YAP oncogenesis in uveal melanoma cells 29 samples shares yap, activity
- GSE227973 MY-COMP, an inhibitor of the transcriptional activity of YAP-B-MYB, identifies NEK2 as a novel mediator of YAP oncogenesis in uveal melanoma cells [RNA-seq] 21 samples shares yap, activity
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.